|
Persistent Pain Management: Challenge of Long Term Opioid Therapy
Released October 2002
Reviewed May 2007
Expiration Date April 30, 2009
Sponsored for Physicians and Nurses by the Dannemiller Memorial Educational Foundation
Sponsored for Pharmacists by Purdue University
Supported by an unrestricted grant from Purdue Pharma L.P.
You will need the latest version of the Macromedia Flash plug-in to view this activity.
Author
Richard Payne, MD
Esther Colliflower Professor
Director, Duke Institute on Care at the End of Life
Duke University Divinity School
Durham, NC
Educational Method
This slide presentation with accompanying notes contains 41 slides and should take approximately 1 hour to complete. The participant should:
- Read the objectives and other introductory information.
- Review the slides and read the notes that accompany them.
- Take the post-test. The post-test can be accessed by clicking on the post-test icon that follows the presentation.
- Complete the evaluation form.
- Participants who complete the post-test and evaluation will be issued a CME/CPE/CE certificate which may be printed at their location. A database of certificates awarded online is maintained at the accrediting agency. No additional certificate will be mailed. Expiration date for credit is April 30, 2009.
Upon successful completion of the activity and post-test, a CME/CPE/CE certificate for up to 1 Category 1 credit, or 1 contact hour, will be issued on-line and the participant will be able to print the certificate at their location. No additional certificate will be mailed. The participant will have unlimited access to their personal transcript, documenting their participation and achievement.
In the event you are unable to print the certificate, please submit the posttest and then email editor@dannemiller.com and a certificate will be mailed to you within two weeks.
Statement of Need
Many strategies exist to treat persistent non-cancer pain. Persistent pain is not a single entity but may have a myriad of causes, perpetuating factors, and responses. Strategies must include behavioral approaches, rehabilitation, and/or different medications, such as opioids. Impediments to opioid use include concerns of respiratory depression, tolerance, addiction, diversion, and regulatory action against the prescriber and others. Pain management is an interdisciplinary field; therefore it is important for all members of the pain management team to understand these important issues.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Identify the barriers to persistent pain management.
- Describe current persistent pain management strategies.
- Describe the use of opioids in the management of persistent pain.
- Identify the difference between opioid tolerance, physical dependence, and addiction.
- Describe the economic burden of persistent pain.
Intended Audience
This program is intended for physicians, nurses, clinical pharmacists, and other healthcare professionals who care for patients experiencing persistent pain.
Accreditation/Designation of Credit
Physicians
The Dannemiller Memorial Educational Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
Nursing
The Dannemiller Memorial Educational Foundation is an approved provider by the California Board of Registered Nursing, Provider Number 4229. Provider approved by the California Board of Registered Nursing, Provider Number 4229 for 1 contact hours.
RNs outside California must verify with their licensing agency for approval of this course.
 
Pharmacy
Purdue University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. This is a continuing education activity of Purdue, an equal access/equal opportunity university. To receive the 1 contact hour of continuing education credit, pharmacists should complete the activity requirements and evaluation at the conclusion of the slide show. Approval is valid from the initial release date of May 1, 2007. The expiration date is April 30, 2009. Program # 018-999-07-010-H01.
Faculty Disclosure
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), the Dannemiller Memorial Educational Foundation requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Accordingly:
Richard Payne is a consultant for AstraZeneca, Elan, Ionix, Johnson & Johnson, Merck & Co, Inc., Pfizer, Inc., Janssen, Purdue Pharma, Rinat, TheraQuest Biosciences, Endo Pharmaceuticals and Xanodyne Pharmaceuticals, Inc. He is a stock shareholder with Rinat, Xanodyne Pharmaceuticals, Inc, and Prism Pharmaceuticals.
The Dannemiller Memorial Educational Foundation staff that was involved in the development of this activity has no financial relationships with any commercial interests that are relevant to this activity.
To resolve identified conflicts of interest, the educational content was fully peer reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based and commercially balanced.
Off-label statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Disclaimer
The contents and views presented in this educational activity are those of the authors and do not necessarily reflect those of the Dannemiller Memorial Educational Foundation or Purdue Pharma, LP. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.
» Click Here To Begin
|
